Industry Urges Court To Reject Patent Test | August 17, 2009 Issue - Vol. 87 Issue 33 | Chemical & Engineering News
Volume 87 Issue 33 | p. 27 | Concentrates
Issue Date: August 17, 2009

Industry Urges Court To Reject Patent Test

Department: Government & Policy
Keywords: patent protection, biotechnology patents, biotechnology industry

The biotechnology industry is urging the Supreme Court to overturn a lower court decision (Bilski v. Doll) that narrowed the means of determining whether a process is eligible for patent protection, arguing that the new standard is likely to exclude unforeseen innovations. In October 2008, the U.S. Court of Appeals for the Federal Circuit ruled that a method or process is patent-eligible only if it is tied to a specific machine or if it transforms a particular article into a different state or different thing altogether. Tom DiLenge, general counsel at the Biotechnology Industry Organization, says the appellate court decision is at odds with the broad standard for process patent eligibility set by the Supreme Court three decades ago. “If the Court of Appeals’ contrary approach in the Bilski case is permitted to stand, it would create uncertainty that would negatively impact investment in biotechnology and thus stifle future growth of this remarkably beneficial industry,” DiLenge says. “Requiring that biotechnology process claims be tied to a machine or a transformation could jeopardize already-issued biotechnology claims and will create uncertainty surrounding future grants of biotechnology patents in these areas.”

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment